mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.8 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.016 |
0.8 |